| Home > Publications Database > The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. |
| Journal Article | DZNE-2020-05835 |
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
2017
Elsevier
New York, NY
This record in other databases:
Please use a persistent id in citations: doi:10.1016/j.immuni.2017.08.008
Abstract: Microglia play a pivotal role in the maintenance of brain homeostasis but lose homeostatic function during neurodegenerative disorders. We identified a specific apolipoprotein E (APOE)-dependent molecular signature in microglia from models of amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and Alzheimer's disease (AD) and in microglia surrounding neuritic β-amyloid (Aβ)-plaques in the brains of people with AD. The APOE pathway mediated a switch from a homeostatic to a neurodegenerative microglia phenotype after phagocytosis of apoptotic neurons. TREM2 (triggering receptor expressed on myeloid cells 2) induced APOE signaling, and targeting the TREM2-APOE pathway restored the homeostatic signature of microglia in ALS and AD mouse models and prevented neuronal loss in an acute model of neurodegeneration. APOE-mediated neurodegenerative microglia had lost their tolerogenic function. Our work identifies the TREM2-APOE pathway as a major regulator of microglial functional phenotype in neurodegenerative diseases and serves as a novel target that could aid in the restoration of homeostatic microglia.
Keyword(s): Alzheimer Disease: genetics (MeSH) ; Alzheimer Disease: metabolism (MeSH) ; Alzheimer Disease: pathology (MeSH) ; Amyloid beta-Peptides: metabolism (MeSH) ; Amyloid beta-Protein Precursor: metabolism (MeSH) ; Animals (MeSH) ; Apolipoproteins E: deficiency (MeSH) ; Apolipoproteins E: genetics (MeSH) ; Apolipoproteins E: metabolism (MeSH) ; Apoptosis: genetics (MeSH) ; Apoptosis: immunology (MeSH) ; Cerebral Cortex: metabolism (MeSH) ; Cerebral Cortex: pathology (MeSH) ; Cluster Analysis (MeSH) ; Disease Models, Animal (MeSH) ; Encephalomyelitis, Autoimmune, Experimental (MeSH) ; Female (MeSH) ; Gene Expression Profiling (MeSH) ; Gene Expression Regulation (MeSH) ; Gene Targeting (MeSH) ; Humans (MeSH) ; Immune Tolerance (MeSH) ; Membrane Glycoproteins: metabolism (MeSH) ; Mice (MeSH) ; Mice, Knockout (MeSH) ; Mice, Transgenic (MeSH) ; Microglia: immunology (MeSH) ; Microglia: metabolism (MeSH) ; Monocytes: immunology (MeSH) ; Monocytes: metabolism (MeSH) ; Neurodegenerative Diseases: genetics (MeSH) ; Neurodegenerative Diseases: immunology (MeSH) ; Neurodegenerative Diseases: metabolism (MeSH) ; Neurons: metabolism (MeSH) ; Phagocytosis: genetics (MeSH) ; Phagocytosis: immunology (MeSH) ; Phenotype (MeSH) ; Plaque, Amyloid: metabolism (MeSH) ; Plaque, Amyloid: pathology (MeSH) ; Receptors, Immunologic: metabolism (MeSH) ; Signal Transduction (MeSH) ; Superoxide Dismutase-1: genetics (MeSH) ; Superoxide Dismutase-1: metabolism (MeSH) ; Transcriptome (MeSH) ; Transforming Growth Factor beta: metabolism (MeSH) ; Amyloid beta-Peptides ; Amyloid beta-Protein Precursor ; Apolipoproteins E ; Membrane Glycoproteins ; Receptors, Immunologic ; Transforming Growth Factor beta ; Trem2 protein, mouse ; Superoxide Dismutase-1
|
The record appears in these collections: |